Mara Vitolins to Prostatic Neoplasms
This is a "connection" page, showing publications Mara Vitolins has written about Prostatic Neoplasms.
Connection Strength
0.674
-
Vitolins MZ, Griffin L, Tomlinson WV, Vuky J, Adams PT, Moose D, Frizzell B, Lesser GJ, Naughton M, Radford JE, Shaw EG. Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer. J Clin Oncol. 2013 Nov 10; 31(32):4092-8.
Score: 0.335
-
Han P, Bidulescu A, Barber JR, Zeisel SH, Joshu CE, Prizment AE, Vitolins MZ, Platz EA. Dietary choline and betaine intakes and risk of total and lethal prostate cancer in the Atherosclerosis Risk in Communities (ARIC) Study. Cancer Causes Control. 2019 Apr; 30(4):343-354.
Score: 0.122
-
Hurwitz LM, Joshu CE, Barber JR, Prizment AE, Vitolins MZ, Jones MR, Folsom AR, Han M, Platz EA. Aspirin and Non-Aspirin NSAID Use and Prostate Cancer Incidence, Mortality, and Case Fatality in the Atherosclerosis Risk in Communities Study. Cancer Epidemiol Biomarkers Prev. 2019 03; 28(3):563-569.
Score: 0.120
-
Thornburg T, Turner AR, Chen YQ, Vitolins M, Chang B, Xu J. Phytanic acid, AMACR and prostate cancer risk. Future Oncol. 2006 Apr; 2(2):213-23.
Score: 0.050
-
Xu J, Thornburg T, Turner AR, Vitolins M, Case D, Shadle J, Hinson L, Sun J, Liu W, Chang B, Adams TS, Zheng SL, Torti FM. Serum levels of phytanic acid are associated with prostate cancer risk. Prostate. 2005 May 15; 63(3):209-14.
Score: 0.047